Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2012
12/12/2012CN102813803A Traditional Chinese medicine for treating infantile cough by using arisaema cum bile
12/12/2012CN102813801A Traditional Tibetan medicine for treating cough and preparation method thereof
12/12/2012CN102813800A Fritillaria lozenge and preparation method thereof
12/12/2012CN102813794A Compound traditional Chinese medicine combination for treating bronchial asthma and preparation method and application thereof
12/12/2012CN102813768A Production method of Arisaema cum Bile and device thereof
12/12/2012CN102813761A Fire-purging and heat-clearing tablets
12/12/2012CN102813756A Pure traditional Chinese medicine composition for treating bovine influenza and preparation method of pure traditional Chinese medicine composition
12/12/2012CN102813721A Pharmaceutical composition for livestock heat clearing and livestock detoxifying and preparation method thereof
12/12/2012CN102813715A Compound medicine for treating post-infectious cough and preparation method and application thereof
12/12/2012CN102813702A Lotion for treating rhinitis
12/12/2012CN102813699A Pharmaceutical composition having effects of heat clearing, detoxifying and anti-inflammation and preparation method thereof
12/12/2012CN102813698A Preparation method of siberian cocklebur fruit pill for treating running nose disease
12/12/2012CN102813695A Method for improving bitter taste of sophora flavescens alkaloids and related preparations thereof
12/12/2012CN102813685A Large specification glabrous scrcandra herb dripping pills and preparation method thereof
12/12/2012CN102813629A Preparation method of tartaric acid valnemulin premixing agent
12/12/2012CN102813625A Preparation method of tartaric acid valnemulin premixing agent
12/12/2012CN102362947B Chinese medicine for treating cough
12/12/2012CN102204973B Medicament for treating cough and preparation method thereof
12/12/2012CN102114005B Tracleer capsule and preparation method thereof
12/12/2012CN102048747B Tulathromycin composition used for treating or preventing pet bacterial diseases and preparation method thereof
12/12/2012CN102038725B Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter
12/12/2012CN102000292B Traditional Chinese medical preparation for treating bronchitis
12/12/2012CN101928234B 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/12/2012CN101687868B Morphinan compounds
12/12/2012CN101675952B Patch for prevention and control of bronchial asthma
12/12/2012CN101658624B Traditional Chinese medicine composite for treating chronic bronchitis and preparation method thereof
12/12/2012CN101584793B Pure natural health-care four-Huai medicine
12/12/2012CN101486677B 5HT2C receptor modulators
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329641 Antiischemic agents; anticholesterol agents; cardiovascular disorders; using granulocyte colony stimulating agents
12/11/2012US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
12/11/2012US8329177 Method of treating hypertrophic cardiomyopathy
12/11/2012CA2553705C 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
12/11/2012CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/06/2012WO2012166646A1 TARGETING p63 TO RE-ACTIVATE DORMANT RESERVE STEM CELLS IN OLFACTORY EPITHELIUM
12/06/2012WO2012166415A1 Heterocyclic autotaxin inhibitors and uses thereof
12/06/2012WO2012165843A2 Composition comprising herbal extracts or fermented products thereof having lactic acid bacteria for preventing or treating respiratory diseases
12/06/2012WO2012165810A2 Pharmaceutical composition containing wogonin as an active ingredient for preventing or treating asthma
12/06/2012WO2012165731A1 Novel usage of rice, rice bran, or chaff extract as histamine receptor antagonist
12/06/2012WO2012165314A1 Amide compound
12/06/2012WO2012163724A1 Triazolopyridine compounds
12/06/2012WO2012163501A1 Nasal pharmaceutical formulation
12/06/2012WO2012163267A1 Compound chemical medicine acting on respiratory disease, preparation process and use thereof
12/06/2012WO2012108635A3 Composition for preventing or treating respiratory disease containing mixed herbal extract of cnidium officinale root and rhei undulati rhizome
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309837 Bronchodilating Beta-Agonist Compositions and Methods
12/06/2012US20120309836 Methods and compositions for administration of trpv1 agonists
12/06/2012US20120309833 Novel bexarotene analogs
12/06/2012US20120309820 Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids
12/06/2012US20120309796 Benzocycloheptene acetic acids
12/06/2012US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
12/06/2012US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases
12/06/2012US20120309776 Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309735 Aminopyrimidines as syk inhibitors
12/06/2012US20120309729 Barrier composition
12/06/2012US20120309727 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/06/2012US20120309726 Combinations comprising antimuscarinic agents and pde4 inhibitors
12/06/2012US20120309725 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
12/06/2012US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309683 USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
12/06/2012US20120309674 Pseudodipeptides as mmp inhibitors
12/06/2012US20120309673 Cysteine protease inhibitors
12/06/2012US20120309672 Treatment of extracellular matrix to reduce inflammation
12/06/2012US20120308671 Nasal ointment based on white petroleum jelly
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308635 Melt extruded thin strips containing coated pharmaceutical
12/06/2012US20120308617 Phospholipid-based inhalation system
12/06/2012US20120308613 Formulations for use in inhaler devices
12/06/2012US20120308609 6-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
12/06/2012US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/06/2012US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308514 Human antibodies that bind human il-12 and methods for producing
12/06/2012US20120308480 Humanized antibodies against tl1a
12/06/2012CA2837046A1 Novel use of rice, rice bran or rice hull extract as a histamine receptor antagonist
12/06/2012CA2836947A1 Anti-emr1 antibodies
12/06/2012CA2836025A1 Nasal pharmaceutical formulation comprising fluticasone
12/05/2012EP2528921A2 7-azoniabicyclo [2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528607A2 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012EP2528601A1 Compositions and methods for prevention and treatment of pulmonary hypertension
12/05/2012EP2528600A1 Dry powder pharmaceutical composition comprising tiotropium and fluticasone
12/05/2012EP2528597A1 Dry powder formulation comprising a pharmaceutical combination of tiotropium bromide, formoterol fumarate and mometasone furoate
12/05/2012EP2528596A1 Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate.
12/05/2012EP2528595A1 Compounds for use in the treatment of diseases
12/05/2012EP2528591A2 Effervescent formulations comprising cefaclor
12/05/2012EP2528590A2 Effervescent dosage forms comprising cephalosporin antibiotic
12/05/2012EP2528589A2 Stable efervescent formulations comprising cefaclor
12/05/2012CN102812048A Allergy inhibitor
12/05/2012CN102812027A Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/05/2012CN102812000A Dp2 Antagonist And Uses Thereof
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 878